NOT KNOWN FACTUAL STATEMENTS ABOUT CONOLIDINE

Andy Chevigné and his staff, RTI-5152-12 is postulated to raise the levels of opioid peptides that bind to classical opioid receptors while in the Mind, causing heightened painkilling activity. The LIH-RTI analysis teams set up a collaboration agreement and filed a joint patent application in December 2020.Before we move forward any more with this